Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Inari Medical Inc
NARICurrent price
50.56 USD
+0.85 USD (+1.71%)
Last closed
49.24 USD
Company
www.inarimedical.com
ISIN
US45332Y1091
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
3 008 586 496 USD
Yield for 12 month
-12.80 %
1Y
3Y
5Y
10Y
15Y
NARI
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Address: 6001 Oak Canyon, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
64.57 USDP/E ratio
–Dividend Yield
–Current Year
+493 632 000 USD
Last Year
+383 471 000 USD
Current Quarter
+153 390 000 USD
Last Quarter
+145 820 000 USD
Current Year
+428 764 001 USD
Last Year
+338 965 000 USD
Current Quarter
+133 544 000 USD
Last Quarter
+122 278 000 USD
Key Figures NARI
1 year
3 years
5 years
10 years
EBITDA
-26 132 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-3.21 %
PEG Ratio
–
Return On Equity TTM
-17.72 %
Wall Street Target Price
64.57 USD
Revenue TTM
574 497 984 USD
Book Value
7.44 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
21.4 %
Dividend Yield
–
Gross Profit TTM
338 965 000 USD
Earnings per share
-1.35 USD
Diluted Eps TTM
-1.35 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-83.9 %
Profit Margin
-13.68 %
Dividend Analytics NARI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NARI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NARI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
232.5581
Enterprise Value Revenue
5.0997
Price Sales TTM
5.2369
Enterprise Value EBITDA
1575.1814
Price Book MRQ
6.9201
Financials NARI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NARI
For 52 weeks
36.73 USD
67.13 USD
50 Day MA
44.43 USD
Shares Short Prior Month
4 248 315
200 Day MA
47.06 USD
Short Ratio
4.51
Shares Short
3 980 407
Short Percent
8.62 %
BeatStart